Diabetic patients with high myopia have a significantly lower choroidal vascularity index (CVI) than those with diabetic retinopathy (DR), according to research published in Frontiers in Cell and ...

Diabetic Retinopathy (DR) is one of the visual abnormality of diabetes which affects the retina. The disease gradually damages the retina and leads to blindness in future. Detection and classification ...

A deep learning system can accurately detect vision-threatening diabetic retinopathy, demonstrating specialist-level diagnostic performance.

However, the role of GLP-1 analogs in diabetic retinopathy (DR), a common complication of diabetes mellitus (DM), remains controversial. Retinal ganglion cells (RGCs) are the only afferent neurons ...

The aim of this review is to provide a clinical update on diabetic retinopathy (DR) for the primary care physician. It should be noted, however, that diabetes can impact other sites within the eye ...

Geriatrics and Aging. 2008;11(6):333-341. Proliferative diabetic retinopathy is clinically characterized by the growth of new blood vessels that arise from the optic disc and/or retina and ...

Danegaptide is an oral therapy for early treatment of non-proliferative diabetic retinopathy (NPDR) and associated edema.

Perfuse Therapeutics reveals promising Phase 2 trial results for PER-001, a potential treatment for glaucoma and diabetic ...

Ophthalmologist , Vitreoretinal Surgeon, talks about how diabetic retinopathy is caused in patients with diabetes as well as treatment and management strategies.

New research has found that the endothelial cell-specific A disintegrin and metalloproteinase domain-containing protein 10 ...

The global Diabetic Retinopathy Market is estimated to be valued at USD 9,830 million in 2025 and is projected to reach USD 18,259.3 million by 2035, registering a compound annual growth rate (CAGR) ...

As the number of South Africans diagnosed with diabetes continues to increase, coupled with an ageing population, the ...